Cancer-associated venous thromboembolism

AA Khorana, N Mackman, A Falanga… - Nature reviews Disease …, 2022 - nature.com
Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial
events) is highly consequential for patients with cancer and is associated with worsened …

[HTML][HTML] Understanding chronic venous disease: a critical overview of its pathophysiology and medical management

MA Ortega, O Fraile-Martínez… - Journal of clinical …, 2021 - mdpi.com
Chronic venous disease (CVD) is a multifactorial condition affecting an important
percentage of the global population. It ranges from mild clinical signs, such as …

Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism

J Ghouse, V Tragante, G Ahlberg, SA Rand… - Nature …, 2023 - nature.com
We report a genome-wide association study of venous thromboembolism (VTE)
incorporating 81,190 cases and 1,419,671 controls sampled from six cohorts. We identify 93 …

[HTML][HTML] Management of lower extremity pain from chronic venous insufficiency: a comprehensive review

V Orhurhu, R Chu, K Xie, GN Kamanyi, B Salisu… - Cardiology and …, 2021 - Springer
Abstract Purpose of Review Chronic venous insufficiency is found to some extent in a large
proportion of the world's population, especially in the elderly and obese. Despite its …

Defining the human and health care costs of chronic venous insufficiency

Y Kim, CYM Png, BJ Sumpio, CS DeCarlo… - Seminars in Vascular …, 2021 - Elsevier
Chronic venous insufficiency (CVI) affects more than 25 million adults in the United States
alone, and more 6 million with advanced stages of venous disease. The high incidence of …

[HTML][HTML] The Role of Biomarkers, Metabolomics, and COVID-19 in Venous Thromboembolism—A Review of Literature

V Della Corte, R Riolo, S Scaglione… - International Journal of …, 2023 - mdpi.com
In recent years, the field of venous thromboembolism has undergone numerous innovations,
starting from the recent discoveries on the role of biomarkers, passing through the role of …

[HTML][HTML] Six-month outcomes of mechanical thrombectomy for treating deep vein thrombosis: analysis from the 500-patient CLOUT registry

A Shaikh, A Zybulewski, J Paulisin, M Bisharat… - Cardiovascular and …, 2023 - Springer
Purpose Mechanical thrombectomy for the treatment of deep vein thrombosis (DVT) is being
increasingly utilized to reduce symptoms and prevent postthrombotic syndrome (PTS), but …

[HTML][HTML] From classical laboratory parameters to novel biomarkers for the diagnosis of venous thrombosis

L Anghel, R Sascău, R Radu, C Stătescu - International journal of …, 2020 - mdpi.com
Venous thrombosis is a common and potentially fatal disease, because of its high morbidity
and mortality, especially in hospitalized patients. To establish the diagnosis of venous …

[HTML][HTML] Bioactive natural compounds with antiplatelet and anticoagulant activity and their potential role in the treatment of thrombotic disorders

S Lamponi - Life, 2021 - mdpi.com
Natural anticoagulant drugs can be obtained from plants, rich in secondary bioactive
metabolites which, in addition to being effective antioxidants, also possess anticoagulant …

Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and platelet indices in patients with acute deep vein thrombosis

L Ming, Z Jiang, J Ma, Q Wang, F Wu, J Ping - Vasa, 2018 - econtent.hogrefe.com
Background: Inflammation is associated with an increased risk of thrombotic events and
complete blood count (CBC) is an easily measured test. The purpose of this study was to …